Literature DB >> 25965392

Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc.

Y Liu1, X Li1, S Zhu1, J-g Zhang2, M Yang1, Q Qin1, S-c Deng1, B Wang3, K Tian1, L Liu1, Y Niu1, C-y Wang1, G Zhao1.   

Abstract

Recent researches demonstrate that microRNAs (miRNAs) are deregulated in numerous cancers and involved in tumorigenesis, whereas their influences on pancreatic cancer (PC) still need further elucidation. The present research revealed that miR-494 was significantly decreased in PC cell lines and tissues. Functional study showed that overexpressed miR-494 could remarkably inhibit proliferation of PC cells both in vitro and in vivo, which was due to induction of apoptosis, G1-phase arrest and senescence. Moreover, upregulated miR-494 significantly prohibited invasion of PC cells. Meanwhile, both c-Myc and SIRT1 was identified as targets of miR-494 through dual luciferase assay and further confirmed by the reverse correlation between miR-494 and c-Myc/SIRT1 in PC samples. Furthermore, co-transfection with c-Myc-RNAi and SIRT1-RNAi synergistically reduced c-Myc and SIRT1 expression, and inhibited proliferation of PC, which simulated the effects of miR-494 overexpression. On the contrary, co-overexpression of c-Myc and SIRT1 effectively rescued inhibition of overexpressed miR-494 on PC cells. The clinical characteristics further revealed that low miR-494 correlated with larger tumor size, late tumor node metastasis stage, lymphatic invasion, distant metastasis and poor prognosis. In conclusion, the present study indicated that miR-494 might serve as predictor and inhibitor in PC by directy downregulating the loop of c-Myc and SIRT1.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25965392     DOI: 10.1038/gt.2015.39

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  34 in total

1.  Human RISC couples microRNA biogenesis and posttranscriptional gene silencing.

Authors:  Richard I Gregory; Thimmaiah P Chendrimada; Neil Cooch; Ramin Shiekhattar
Journal:  Cell       Date:  2005-11-03       Impact factor: 41.582

Review 2.  Reflecting on 25 years with MYC.

Authors:  Natalie Meyer; Linda Z Penn
Journal:  Nat Rev Cancer       Date:  2008-12       Impact factor: 60.716

3.  Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.

Authors:  Beibei Mao; Guowei Zhao; Xiang Lv; Hou-Zao Chen; Zheng Xue; Ben Yang; De-Pei Liu; Chih-Chuan Liang
Journal:  Int J Biochem Cell Biol       Date:  2011-07-22       Impact factor: 5.085

4.  Hypermethylation of HIC1 promoter and aberrant expression of HIC1/SIRT1 might contribute to the carcinogenesis of pancreatic cancer.

Authors:  Gang Zhao; Qi Qin; Jungang Zhang; Yang Liu; Shichang Deng; Lin Liu; Bo Wang; Kui Tian; Chunyou Wang
Journal:  Ann Surg Oncol       Date:  2012-05-03       Impact factor: 5.344

5.  Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs.

Authors:  Lee P Lim; Nelson C Lau; Philip Garrett-Engele; Andrew Grimson; Janell M Schelter; John Castle; David P Bartel; Peter S Linsley; Jason M Johnson
Journal:  Nature       Date:  2005-01-30       Impact factor: 49.962

6.  MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

Authors:  Mark Bloomston; Wendy L Frankel; Fabio Petrocca; Stefano Volinia; Hansjuerg Alder; John P Hagan; Chang-Gong Liu; Darshna Bhatt; Cristian Taccioli; Carlo M Croce
Journal:  JAMA       Date:  2007-05-02       Impact factor: 56.272

7.  MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3.

Authors:  Florin M Selaru; Alexandru V Olaru; Takatsugu Kan; Stefan David; Yulan Cheng; Yuriko Mori; Jian Yang; Bogdan Paun; Zhe Jin; Rachana Agarwal; James P Hamilton; John Abraham; Christos Georgiades; Hector Alvarez; Perumal Vivekanandan; Wayne Yu; Anirban Maitra; Michael Torbenson; Paul J Thuluvath; Gregory J Gores; Nicholas F LaRusso; Ralph Hruban; Stephen J Meltzer
Journal:  Hepatology       Date:  2009-05       Impact factor: 17.425

8.  Bcl2 enhances c-Myc-mediated MMP-2 expression of vascular smooth muscle cells.

Authors:  Qun Lu; Wang Hong
Journal:  Cell Signal       Date:  2009-03-01       Impact factor: 4.315

9.  c-MYC and SIRT1 locked in a vicious cycle.

Authors:  Antje Menssen; Heiko Hermeking
Journal:  Oncotarget       Date:  2012-02

10.  A microRNA expression signature of human solid tumors defines cancer gene targets.

Authors:  Stefano Volinia; George A Calin; Chang-Gong Liu; Stefan Ambs; Amelia Cimmino; Fabio Petrocca; Rosa Visone; Marilena Iorio; Claudia Roldo; Manuela Ferracin; Robyn L Prueitt; Nozumu Yanaihara; Giovanni Lanza; Aldo Scarpa; Andrea Vecchione; Massimo Negrini; Curtis C Harris; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-03       Impact factor: 11.205

View more
  37 in total

1.  MiR-377 inhibits the proliferation of pancreatic cancer by targeting Pim-3.

Authors:  Weihua Chang; Menggang Liu; Jianhua Xu; Hangwei Fu; Bo Zhou; Tao Yuan; Ping Chen
Journal:  Tumour Biol       Date:  2016-09-16

2.  MicroRNAs are key regulators of hepatocellular carcinoma (HCC) cell dissemination-what we learned from microRNA-494.

Authors:  Margarita González-Vallinas; Kai Breuhahn
Journal:  Hepatobiliary Surg Nutr       Date:  2016-08       Impact factor: 7.293

Review 3.  Non-coding RNAs in pancreatic cancer: challenges and opportunities for clinical application.

Authors:  V Taucher; H Mangge; J Haybaeck
Journal:  Cell Oncol (Dordr)       Date:  2016-04-08       Impact factor: 6.730

4.  microRNA-494 is a potential prognostic marker and inhibits cellular proliferation, migration and invasion by targeting SIRT1 in epithelial ovarian cancer.

Authors:  Aijun Yang; Xuenan Wang; Chunna Yu; Zhenzhen Jin; Lingxia Wei; Jinghe Cao; Qin Wang; Min Zhang; Lin Zhang; Lei Zhang; Cuifang Hao
Journal:  Oncol Lett       Date:  2017-06-30       Impact factor: 2.967

Review 5.  MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.

Authors:  Seyed Esmaeil Ahmadi; Samira Rahimi; Bahman Zarandi; Rouzbeh Chegeni; Majid Safa
Journal:  J Hematol Oncol       Date:  2021-08-09       Impact factor: 17.388

6.  MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer.

Authors:  Yi Niu; Yan Jin; Shi-Chang Deng; Shi-Jiang Deng; Shuai Zhu; Yang Liu; Xiang Li; Chi He; Ming-Liang Liu; Zhu Zeng; Heng-Yu Chen; Jian-Xin Zhong; Zeng Ye; Chun-You Wang; Gang Zhao
Journal:  Oncogene       Date:  2018-01-18       Impact factor: 9.867

7.  miR-494 suppresses tumor growth of epithelial ovarian carcinoma by targeting IGF1R.

Authors:  Na Li; Xiaosu Zhao; Lufei Wang; Shi Zhang; Manhua Cui; Jin He
Journal:  Tumour Biol       Date:  2015-12-22

8.  MicroRNA-494 inhibits proliferation and metastasis of osteosarcoma through repressing insulin receptor substrate-1.

Authors:  Xiaodong Zhi; Kai Wu; Deshui Yu; Yansong Wang; Yang Yu; Peng Yan; Gang Lv
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 3.940

Review 9.  Regulation of the Telomerase Reverse Transcriptase Subunit through Epigenetic Mechanisms.

Authors:  Kayla A Lewis; Trygve O Tollefsbol
Journal:  Front Genet       Date:  2016-05-09       Impact factor: 4.599

Review 10.  The Quest for Targets Executing MYC-Dependent Cell Transformation.

Authors:  Markus Hartl
Journal:  Front Oncol       Date:  2016-06-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.